Telangana bets big on drug discovery hub

Hyderabad: The Telangana government is preparing a plan to move Hyderabad up the pharmaceutical value chain by creating infrastructure for developing new medicines, people familiar with the matter told ET.

The plan, being discussed with industry stakeholders and technology bodies, including Nasscom, seeks to bring together global and Indian pharmaceutical companies, global capability centres (GCCs), research institutions, startups and investors to create an integrated ecosystem for drug discovery and commercialisation.

“We are creating the conditions for the next generation of therapies to be discovered, developed and delivered from Telangana,” IT and industries minister D Sridhar Babu told ET.

Hyderabad already ranks among the world’s leading pharmaceutical manufacturing hubs, contributing nearly a third of the global vaccine output. This gives it a foundation to expand into drug discovery and innovation.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs